Exane Derivatives Iqvia Holdings Inc. Transaction History
Exane Derivatives
- $157 Million
- Q2 2022
A detailed history of Exane Derivatives transactions in Iqvia Holdings Inc. stock. As of the latest transaction made, Exane Derivatives holds 490 shares of IQV stock, worth $97,995. This represents 0.07% of its overall portfolio holdings.
Number of Shares
490
Previous 490
-0.0%
Holding current value
$97,995
Previous $113,000
6.19%
% of portfolio
0.07%
Previous 0.03%
Shares
8 transactions
Others Institutions Holding IQV
# of Institutions
1,143Shares Held
142MCall Options Held
828KPut Options Held
951K-
Vanguard Group Inc Valley Forge, PA20MShares$4.01 Billion0.09% of portfolio
-
Black Rock Inc. New York, NY15.2MShares$3.05 Billion0.07% of portfolio
-
State Street Corp Boston, MA7.76MShares$1.55 Billion0.08% of portfolio
-
Geode Capital Management, LLC Boston, MA4.1MShares$819 Million0.08% of portfolio
-
Alliancebernstein L.P. New York, NY3.89MShares$778 Million0.32% of portfolio
About IQVIA HOLDINGS INC.
- Ticker IQV
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 185,740,000
- Market Cap $37.1B
- Description
- IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The ...